Focus Investment Banking

JANUARY 18, 2024

It has taken two years to return to those levels, after 2022 and 2023 were burdened with interest rate hikes and fears of a recession. In that environment, very few firms sought IPOs, and there was a major slowdown in overall exits, whether private or public. The post Will There Be an IPO for a Specialty Consulting Company in 2024?

IPO

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A

The Deal

OCTOBER 17, 2023

Direct-to-consumer businesses, darlings of the investor community in 2021, saw their techlike valuations plummet. Public markets, however, have been tepid, with the much-awaited IPO of L Catterton Management Ltd. “We do think some of the transactions that may have launched in 2022 will start to get done in the back half of 2023.”

M&A

Cooley M&A

FEBRUARY 7, 2023

That said, cross-border M&A remained largely resilient in 2022, with a return to healthy pre-pandemic levels, and while the types of deals we see in 2023 may evolve, many observers believe that deal volume will remain buoyant throughout the year. Regulators, particularly in the US, are becoming more skeptical of remedies in merger cases.

M&A

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity. billion, Mirati for $5.8

M&A

The Deal

AUGUST 9, 2023

M&A is a central part of SymphonyAI’s growth strategy as the company prepares for a potential private placement and, eventually, an IPO. “We’re billion valuation in 2021. Dhawan became CEO of SymphonyAI in 2022, replacing founder Romesh Wadhwani. Enterprise AI specialist DataRobot Inc.

M&A

Focus Investment Banking

APRIL 14, 2024

bakery market has shown steady historical growth, with industry revenue rising roughly 4% annum from 2004 to 2022. Healthy competition for the top bakeries has increased valuations in recent years, with strong purchase price / cash flow (EBITDA) multiples. The $75 billion U.S. bakery industry is on an upward trajectory.

M&A

Mergers and Inquisitions

NOVEMBER 1, 2023

This chart of PE deal activity from 2001 to 2022 in the Bain Capital Healthcare Private Equity report sums up the market quite well: In short, healthcare had never been a huge sector for private equity, but activity ramped up in the late 2010s into the early 2020s, and it’s now one of the top industries by dollar volume (right after tech).

Private Equity

Cooley M&A

JANUARY 20, 2022

Undeterred by the pandemic, high target valuations, intense competition for attractive assets and regulatory uncertainty, the deal world again proved that robust activity is possible with distributed workforces Zooming through the market faster than you can say, “You’re on mute.”. R&W insurance shaping expectations in tech M&A.

M&A

Cooley M&A

FEBRUARY 1, 2024

2023’s much-discussed downturn in mergers & acquisitions – with global M&A volume and value down 6% and 17%, respectively, from 2022 – was largely driven by the slowdown in the tech sector, with global tech M&A volumes down 51% year over year, while other sectors saw marked increases. [1]

M&A

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 trillion. [2] trillion.

M&A

Cooley M&A

JANUARY 20, 2022

While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. on transactions dominating the life sciences landscape into 2022. [4].

M&A

MergersCorp M&A International

MAY 27, 2025

After a boom in 2020 and 2021 that saw record-breaking volumes, the market cooled considerably in 2022 and 2023. The Basics At its core, a SPAC is a shell company with no commercial operations, formed solely to raise capital through an Initial Public Offering (IPO) with the express purpose of acquiring an existing private company.

IPO

Focus Investment Banking

NOVEMBER 18, 2024

This active M&A market continued for almost three years until mid-to-late 2022 when interest rates increased rapidly, making it much more expensive to buy or build new car wash locations. Alternative Solutions: I would expect to see other alternative options used by certain platforms to extend their hold periods.

Private Equity

Cooley M&A

FEBRUARY 3, 2025

Over the course of the year, many of the headwinds that have slowed tech M&A activity since 2022 began to abate as interest rates moderated, the acquisition financing market returned and equity markets reached new highs. billion acquisition of Altair, IBMs pending $6.4 billion acquisition of HashiCorp and a Permira-led consortiums $6.9

M&A